The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
Open accessAbstract
BACKGROUND: In a previous phase 3 trial of adjuvant chemotherapy after resection of non-small-cell lung cancer, a combination of uracil and tegafur (often referred to as UFT) taken orally was shown to prolong survival. A subgroup analysis disclosed that most patients who benefited had pathological stage I adenocarcinoma. METHODS: We randomly assigned patients with completely resected pathological stage I adenocarcinoma of the lung to receive either oral uracil-tegafur (250 mg of tegafur per square meter of body-surface area per day) for two years or no treatment. Randomization was performed with stratification according to the pathological tumor category (T1 vs. T2), sex, and age. The primary end point was overall survival. RESULTS: From January 1994 through March 1997, 999 patients were enrolled. Twenty patients were found to be ineligible and were excluded from the analysis after randomization; 491 patients were assigned to receive uracil-tegafur and 488 were assigned to observation. The median duration of follow-up for surviving patients was 73 months. The difference in overall survival between the two groups was statistically significant in favor of the uracil-tegafur group (P=0.04 by a stratified log-rank test). Grade 3 toxic effects occurred in 10 of the 482 patients (2 percent) who actually received uracil-tegafur. CONCLUSIONS: Adjuvant chemotherapy with uracil-tegafur improves survival among patients with completely resected pathological stage I adenocarcinoma of the lung.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982) · AMERICAN JOURNAL OF CLINICAL ONCOLOGY · doi:10.1097/00000421-198212000-00014 · Cited by 11,647
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., & Johnson, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011954 · Cited by 4,955
A New International Staging System for Lung Cancer
Mountain, C. F. (1986) · Chest · doi:10.1378/chest.89.4_supplement.225s · Cited by 1,659
Small adenocarcinoma of the lung. Histologic characteristics and prognosis
Noguchi, M., Morikawa, A., Kawasaki, M., Matsuno, Y., Yamada, T., Hirohashi, S., Kondo, H., & Shimosato, Y. (1995) · Cancer · doi:10.1002/1097-0142(19950615)75:12<2844::aid-cncr2820751209>3.0.co;2-# · Cited by 1,134
WHO handbook for reporting results of cancer treatment
Sylvester, R. (1980) · Controlled Clinical Trials · doi:10.1016/0197-2456(80)90009-4 · Cited by 1,055
Scagliotti, G. V. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg059 · Cited by 593
Repeated assessment of results in clinical trials of cancer treatment
Haybittle, J. L. (1971) · The British Journal of Radiology · doi:10.1259/0007-1285-44-526-793 · Cited by 517
Vokes, E. E., Herndon, J. E., Crawford, J., Leopold, K. A., Perry, M. C., Miller, A. A., & Green, M. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.054 · Cited by 370
Schoenfeld, D. A., & Richter, J. R. (1982) · Biometrics · doi:10.2307/2530299 · Cited by 354
Wada, H., Hitomi, S., & Teramatsu, T. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1048 · Cited by 292
Self-citationFeld, R., Rubinstein, L., Thomas, P. A., & The Lung Cancer Study Group (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.299 · Cited by 171
Ho, D. H., Pazdur, R. M., Covington, W., et al. (1998) · PubMed · Cited by 124
Yonekura, K., Basaki, Y., Chikahisa, L., et al. (1999) · PubMed · Cited by 116
Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease
Breathnach, O. S., Kwiatkowski, D. J., Finkelstein, D., Godleski, J. J., Sugarbaker, D. J., Johnson, B. E., & Mentzer, S. J. (2001) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.110190 · Cited by 84
Braichotte, D. R., Wagnières, G., Bays, R., Monnier, P., & Bergh, H. E. D. V. (1995) · Cancer · doi:10.1002/1097-0142(19950601)75:11<2677::aid-cncr2820751106>3.0.co;2-d · Cited by 82
Phase II Study of UFT in Patients With Advanced Non-Small Cell Lung Cancer
Keicho, N., Saijo, N., Shinkai, T., et al. (1986) · Japanese Journal of Clinical Oncology · doi:10.1093/oxfordjournals.jjco.a039130 · Cited by 42
Mýrdal, G., Lambe, M. P., Gustafsson, G., Nilsson, K. L., & Ståhle, E. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)04321-7 · Cited by 30
Ichinose, Y., Yosimori, K., Yoneda, S., Kuba, M., Kudoh, S., Niitani, H., & for the Japan UFT Lung Cancer Study Group (2000) · Cancer · Cited by 29
Self-citationTanaka, F., Otake, Y., Yanagihara, K., Yamada, T., Miyahara, R., Kawano, Y., Li, M., Inui, K., & Wada, H. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1579 · Cited by 26
Self-citationSaito, J., Nakai, Y., Saijo, Y., et al. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00183-5 · Cited by 17
Cited by
Uesaka, K., Boku, N., Fukutomi, A., Okamura, Y., Konishi, M., Matsumoto, I., Kaneoka, Y., Shimizu, Y., Nakamori, S., Sakamoto, H., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30583-9 · Cited by 1,115
Hu, Z., Chen, X., Zhao, Y., Tian, T., Jin, G., Shu, Y., Chen, Y., Xu, L., Zen, K., Zhang, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9342 · Cited by 798
Gene Expression Signatures for Predicting Prognosis of Squamous Cell and Adenocarcinomas of the Lung
Raponi, M., Zhang, Y., Yu, J., Chen, G., Lee, G., Taylor, J. M. G., MacDonald, J., Thomas, D., Moskaluk, C., Wang, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1191 · Cited by 435
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
Burdett, S., Pignon, J. P., Tierney, J., Tribodet, H., Stewart, L., Le Pechoux, C., Aupérin, A., Le Chevalier, T., Stephens, R. J., Arriagada, R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011430 · Cited by 360
Self-citationGlutathione S transferase deficiency and passive smoking increase childhood asthma
Kabesch, M. (2004) · Thorax · doi:10.1136/thx.2003.016667 · Cited by 209
Metadata
- Authors
- Kato, H., Ichinose, Y., Ohta, M., Hata, E., Tsubota, N., Tada, H., Watanabe, Y., Wada, H., Tsuboi, M., Hamajima, N., & Ohta, M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-04-22
- Volume
- 350
- Issue
- 17
- Pages
- 1713-1721
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2075549113
- Cited by
- 818
- References
- 21
- FWCI
- 59.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.